Nobelprize.org
Lists of Nobel Prizes and Laureates

Special Article


Yeast Pre-mRNA is Composed of Two Populations with Distinct Kinetic Properties

DAVID J. ELLIOTT* AND MICHAEL ROSBASH
Department of Biology, Howard Hughes Medical Institute, Brandeis University, Waltham, Massachusetts 02254




Abstract
As an approach to the study of yeast pre-mRNA splicing in vivo, we have examined properties of transcripts derived from a gal-UAS intron-containing fusion gene encoding RP51A and a series of its derivatives. RNA half-life measurements were carried out after transcription initiation was blocked by the addition of glucose. Pre-mRNA encoded by GalRP51A decayed with a half life of ~6 min and was substantially polyedenylated, and transcripts derived from a nonspliced version of the same gene decayed with a similar half-life (~4 min). A comparison of the steady-state levels of these two transcripts suggests that the bulk of GalRP51A pre-mRNA is processed much more rapidly, with an average lifetime of about 2 s. We propose that this inferred population of rapidly processed molecules is spliced cotranscriptionally and that it is the principal precursor to GalRP51A mRNA. Although the pre-mRNA molecules detected are therefore unlikely to be the major splicing precursors, an in vivo assay suggests that they are likely to have bound splicing factors. They must then be spliced much more slowly than most primary transcripts, or not spliced at all and then degraded through a different cellular pathway. As a result of its comparatively long lifetime, this minor fraction of the pre-mRNA population makes up the majority of the steady-state level of GalRP51A pre-mRNA.

EXPERIMENTAL CELL RESEARCH 229
181 - 188 (1996)
ARTICLE NO. 0357
Copyright © 1996 Academic Press, Inc.

*Address (1996): MRC Human Genetics Unit, Chromosome Biology Section, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland

 

Share this:
To cite this page
MLA style: "Yeast Pre-mRNA is Composed of Two Populations with Distinct Kinetic Properties". Nobelprize.org. Nobel Media AB 2013. Web. 17 Apr 2014. <http://www.nobelprize.org/nobel_organizations/nobelfoundation/symposia/medicine/ns100/elliot.html>

Recommended:

On 27 November 1895 Alfred Nobel signed his last will in Paris.

 

Try to save some patients and learn about human blood types!

 

Discover the 2012 awarded research on stem cells and cell signalling.